SN

Shelby Newsad

Compound

United States

Invests in

Locations:

  • Min Investment:

    $400,000.00
  • Max Investment:

    $1,500,000.00
  • Target Investment:

    $1,000,000.00

Work Experience

2022

  • Investor

    2022

  • PhD Candidate Plant Science

    2018 - 2022

    · Working with synthetic biology techniques to investigate vitamin-repressible systems · Exploiting synthetic ecology to study microbial-algae vitamin dependence via “-omics approaches” and mutageneses · Cambridge Trust/Newnham Graduate Research Scholar

  • MPhil Candidate in Bioscience Enterprise

    2017 - 2020

    · Class President · Cambridge Consulting Network: Strategy consulting for biotechnology AI start-up · EnterpriseTECH consulting: Consultant for biotechnology start-up through Enterprise Center at Judge Business School

2021 - 2022

  • Analyst

    2021 - 2022

2020 - 2021

  • Team Lead Due Diligence Projects

    2020 - 2021

    · Organise, co-ordinate, and lead a group of 4 students in conducting due diligence for early-stage healthcare start-ups · ~1 deep diligence of company per week · Liaise directly with CEO of Start Codon regarding recommendation for further due diligence

  • Summer Intern

    2020 - 2020

    · Conducted landscape analysis reporting industry trends and potential investment opportunities to Senior Associate and team (including the Managing Partner) · Completed scientific due diligence on potential investment opportunities, including patent and literature searches · Participated in contacting and liaising with potential investment opportunities

  • Founder and President

    2019 - 2020

  • Leader of Tomorrow

    2019 - 2020

  • President

    2018 - 2019

    Initiator of Due Diligence Projects and "Breaking into Investing" speaker and case-study series which: · Gives students hand-on experience to the due diligence process in venture capital · Brings unparalleled networking opportunities to Cambridge University students in the field of biotechnology and technology investing · Provides a learning environment where investing case-studies are taught by experts

  • Consultant

    2018 - 2018

    Provided strategy consulting advice to Cambridge-based AI drug discovery start up regarding: · Data acquisition companies to train AI algorithm · Most attractive pharmaceutical partners

2018 - 2018

  • Foresight & Scouting

    2018 - 2018

    · Developed an investment proposal which was assessed and funded by the board of Merck · Reported to the innovation field leader and CIO · Contributed to strategy meetings with a task to identify market openings in the Innovation Center: New Business Builder Team.